Scarica l'app Stockscreener
11.49
2.13%
-0.25
Precedente Chiudi:
$11.74
Aprire:
$11.91
Volume 24 ore:
3.55M
Relative Volume:
1.27
Capitalizzazione di mercato:
$905.29M
Reddito:
$65,400
Utile/perdita netta:
$-46.34M
Rapporto P/E:
-12.49
EPS:
-0.92
Flusso di cassa netto:
$-38.74M
1 W Prestazione:
+8.81%
1M Prestazione:
+0.61%
6M Prestazione:
-22.68%
1 anno Prestazione:
+31.01%
Intervallo 1D:
$11.49
$11.91
Intervallo di 1 settimana:
$10.65
$12.10
Portata 52W:
$5.60
$17.43
CorMedix Inc Stock (CRMD) Company Profile
Nome
CorMedix Inc
Settore
Industria
Telefono
908-517-9500
Indirizzo
400 Connell Drive, 5th Floor, Suite 5000, Berkeley Heights, NJ
Confronta CRMD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CRMD
CorMedix Inc
|
11.49 | 924.98M | 65,400 | -46.34M | -38.74M | -0.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
CorMedix Inc Stock (CRMD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-20 | Aggiornamento | D. Boral Capital | Hold → Buy |
| 2025-06-30 | Downgrade | D. Boral Capital | Buy → Hold |
| 2025-06-30 | Iniziato | H.C. Wainwright | Buy |
| 2025-03-07 | Iniziato | Leerink Partners | Outperform |
| 2025-01-13 | Iniziato | D. Boral Capital | Buy |
| 2024-08-26 | Iniziato | Rodman & Renshaw | Buy |
| 2023-08-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-02-17 | Iniziato | Needham | Buy |
| 2020-09-29 | Iniziato | JMP Securities | Mkt Outperform |
| 2020-09-21 | Iniziato | Truist | Buy |
| 2019-12-18 | Iniziato | B. Riley FBR | Buy |
| 2019-03-26 | Reiterato | H.C. Wainwright | Buy |
| 2018-12-06 | Iniziato | ROTH Capital | Buy |
| 2017-09-25 | Reiterato | H.C. Wainwright | Buy |
| 2017-08-10 | Reiterato | Rodman & Renshaw | Buy |
| 2017-05-05 | Reiterato | Rodman & Renshaw | Buy |
| 2016-11-11 | Reiterato | FBR & Co. | Outperform |
| 2016-03-17 | Reiterato | FBR Capital | Outperform |
| 2016-03-03 | Iniziato | FBR Capital | Outperform |
| 2015-11-16 | Reiterato | ROTH Capital | Neutral |
| 2015-10-29 | Reiterato | ROTH Capital | Neutral |
| 2015-05-06 | Downgrade | ROTH Capital | Buy → Neutral |
| 2014-12-08 | Reiterato | ROTH Capital | Buy |
| 2011-10-03 | Downgrade | Maxim Group | Buy → Hold |
Mostra tutto
CorMedix Inc Borsa (CRMD) Ultime notizie
Cormedix Director Makes a Significant Stock Sale! - TipRanks
Cormedix Stock Soars Pre-Market After Earnings Beat, Higher Full-Year Guidance - MSN
CRMD Up More Than 40% YTD: Time to Buy, Sell or Hold the Stock? - sharewise.com
CorMedix director Dillione sells $408,000 in stock By Investing.com - Investing.com South Africa
CorMedix director Dillione sells $408,000 in stock - Investing.com
Steven Lefkowitz Implements A Sell Strategy: Offloads $475K In Cormedix Stock - Benzinga
CorMedix Inc. Stock (CRMD) Opinions on Insider Selling and Growth Metrics - Quiver Quantitative
Lefkowitz Steven W, director at CorMedix, sells $475k in CRMD stock - Investing.com Canada
CorMedix (CRMD): Is the Market Mispricing This Underappreciated Anti-Infective Growth Story? - Yahoo Finance
Does CorMedix (CRMD) Have the Potential to Rally 68.74% as Wall Street Analysts Expect? - Finviz
CorMedix (CRMD) Upgraded to Strong Buy: Here's What You Should Know - sharewise.com
Best Value Stocks to Buy for December 8th - sharewise.com
New Strong Buy Stocks for December 8th - Zacks Investment Research
CorMedix Shares Garner Strong Analyst Confidence Following Robust Earnings - AD HOC NEWS
Can DefenCath Continue to Aid CorMedix's Long-Term Growth Ahead? - sharewise.com
CorMedix director Dillione sells $466k in shares By Investing.com - Investing.com Nigeria
Is CorMedix Stock Still Attractive After Strong Multi Year Gains And Recent Volatility In 2025 - Yahoo Finance
CorMedix director Dillione sells $466k in shares - Investing.com
Is CorMedix (NASDAQ:CRMD) Using Too Much Debt? - 富途牛牛
How (CRMD) Movements Inform Risk Allocation Models - news.stocktradersdaily.com
Deep Track Capital, LP's Strategic Acquisition of Cormedix Inc S - GuruFocus
Will CorMedix Inc. (19KA) stock benefit from sector leadershipBuy Signal & Reliable Volume Spike Trade Alerts - Newser
Is CorMedix Inc. stock supported by innovation pipelineQuarterly Profit Report & Risk Managed Investment Entry Signals - Newser
Will CorMedix Inc. (19KA) stock see insider accumulationLong Setup & Accurate Entry/Exit Alerts - Newser
Should I buy CorMedix Inc. (19KA) stock before earnings seasonJuly 2025 Earnings & Daily Stock Trend Reports - Newser
Can CorMedix Inc. stock sustain revenue growthWeekly Profit Summary & Consistent Return Investment Signals - Newser
Will CorMedix Inc. stock see PE expansionRate Cut & High Accuracy Trade Signal Alerts - Newser
Cormedix (CRMD) Stock Analysis Report | Financials & Insights - Benzinga
Is CorMedix Inc. stock a bargain at current levelsTrade Entry Report & Short-Term Trading Opportunity Alerts - Newser
Would You Still Hold Cormedix Stock If It Fell Another 30%? - Trefis
Pharming Group Posts Upbeat Q3 Results, Joins On Holding, BigBear.ai Holdings And Other Big Stocks Moving Higher On Wednesday - Sahm
CorMedix director Dillione sells $261,585 in CRMD stock By Investing.com - Investing.com Australia
At Cormedix, Janet Dillione Chooses To Exercise Options, Resulting In $158K - Benzinga
CorMedix director Dillione sells $261,585 in CRMD stock - Investing.com India
CorMedix Director Janet Dillione Sells 26,343 Shares - TradingView
Dir Dillione Sells 26,343 ($261.6K) Of CorMedix Inc [CRMD] - TradingView
CorMedix (CRMD) Is Down 6.3% After Strong Q3 Results and $87.6M Shelf Registration Filed - simplywall.st
What drives CorMedix Inc stock priceAnalyst Downgrades & Small Capital Trading Plans - earlytimes.in
Assessing CorMedix (CRMD): Is the Current Share Price Reflecting Its True Value? - Yahoo Finance
Dir Dillione Files To Sell 73,000 Of CorMedix Inc [CRMD] - TradingView
H.C. Wainwright Raises the PT on CorMedix Inc. (CRMD), Keeps a Buy - MSN
American Kidney Fund Hosts Third Patient Access Initiative Summit to Address Barriers to Kidney Care and Propose Innovative Solutions - GlobeNewswire Inc.
Will CorMedix Inc. (19KA) stock deliver compounding returns2025 Technical Patterns & Growth Focused Stock Pick Reports - newser.com
How institutional buying supports CorMedix Inc. stockJuly 2025 Opening Moves & Risk Controlled Swing Trade Alerts - newser.com
Cormedix Inc (CRMD) Q3 2025 Earnings Call Highlights: Record Financial Performance and ... By GuruFocus - Investing.com Canada
Why CorMedix Inc. (19KA) stock attracts HNW investorsTrend Reversal & High Conviction Trade Alerts - newser.com
CorMedix Inc Azioni (CRMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.08%
0.91%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):